| Target name | Target organism | UniProt identifier | EC50 | IC50 | Kd | Ki | Source |
|---|
| Plasmodium falciparum | Plasmodium falciparum | | | = 0.038 ug.mL-1|= 0.0277 ug.mL-1 | | | NPASS |
| SK-OV-3 | Homo sapiens | | | = 0.18 ug.mL-1|= 100.0 nM | | | NPASS |
| SK-MEL | Homo sapiens | | | = 0.25 ug.mL-1 | | | NPASS |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | | | > 20000.0 nM|> 19952.62 nM | | | NPASS |
| Reverse transcriptase | Human immunodeficiency virus 1 | | | >428000 nM | | | BindingDB |
| Vero | Chlorocebus aethiops | | | = 5.3 ug.mL-1 | | | NPASS |
| Leukocyte adhesion glycoprotein LFA-1 alpha | Homo sapiens | P20701 | | > 10.0 ug.mL-1 | | | NPASS |
| HeLa | Homo sapiens | | | = 7600.0 nM | | | NPASS |
| KB | Homo sapiens | | | = 0.33 ug.mL-1 | | | NPASS |
| Integrin alpha-L | Homo sapiens | P20701 | | >21400 nM | | | BindingDB |
| HL-60 | Homo sapiens | | | = 14.9 ug.mL-1 | | | NPASS |
| Entamoeba histolytica | Eoeba histolytica | | | = 3.26 ug.mL-1 | | | NPASS |
| BT-549 | Homo sapiens | | | = 0.86 ug.mL-1 | | | NPASS |
| A549 | Homo sapiens | | | = 3000.0 nM | | | NPASS |
| Leishmania donovani | Leishmadonovani | | | = 0.03 ug.mL-1 | | | NPASS |
